ACRV
Price
$1.50
Change
-$0.02 (-1.32%)
Updated
Jul 31 closing price
Capitalization
64.2M
16 days until earnings call
Intraday BUY SELL Signals
DNA
Price
$8.09
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Capitalization
528.48M
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRV vs DNA

ACRV vs DNA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACRV vs. DNA commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and DNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (ACRV: $1.50 vs. DNA: $8.09)
Brand notoriety: ACRV and DNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 104% vs. DNA: 55%
Market capitalization -- ACRV: $64.2M vs. DNA: $528.48M
ACRV [@Biotechnology] is valued at $64.2M. DNA’s [@Biotechnology] market capitalization is $528.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileDNA’s FA Score has 1 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • DNA’s FA Score: 1 green, 4 red.
According to our system of comparison, ACRV is a better buy in the long-term than DNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while DNA’s TA Score has 5 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 6 bearish.
  • DNA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а -6.25% price change this week, while DNA (@Biotechnology) price change was +9.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 19, 2026.

DNA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($528M) has a higher market cap than ACRV($64.2M). DNA YTD gains are higher at: -2.647 vs. ACRV (-37.759). ACRV has higher annual earnings (EBITDA): -80.93M vs. DNA (-251.5M). DNA has more cash in the bank: 373M vs. ACRV (97.7M). ACRV has less debt than DNA: ACRV (2.42M) vs DNA (411M). DNA has higher revenues than ACRV: DNA (151M) vs ACRV (0).
ACRVDNAACRV / DNA
Capitalization64.2M528M12%
EBITDA-80.93M-251.5M32%
Gain YTD-37.759-2.6471,426%
P/E RatioN/AN/A-
Revenue0151M-
Total Cash97.7M373M26%
Total Debt2.42M411M1%
TECHNICAL ANALYSIS
Technical Analysis
ACRVDNA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
89%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signal:
Gain/Loss:
DNA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALSAX13.63N/A
N/A
Alger Small Cap Growth A
AWPIX22.86-0.02
-0.09%
AB Sustainable Intl Thematic I
DIFFX12.90-0.03
-0.23%
MFS Diversified Income R3
LSVFX12.98-0.03
-0.23%
LSV Global Managed Volatility Instl
PRPPX17.87-0.08
-0.45%
Principal International Equity R3

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-1.32%
ALLR - ACRV
48%
Loosely correlated
-1.63%
CRMD - ACRV
41%
Loosely correlated
+0.53%
DNA - ACRV
38%
Loosely correlated
N/A
RAPP - ACRV
37%
Loosely correlated
-4.21%
IMRX - ACRV
36%
Loosely correlated
-2.36%
More